C22.2 Hepatoblastoma

Name of the Condition

• Hepatoblastoma

Summary

Hepatoblastoma is a rare type of primary liver cancer that primarily affects infants and young children. It originates from immature liver cells (hepatoblasts) and can impair liver function, potentially spreading to other parts of the body if untreated. The condition is the most common malignant liver tumor in children under 5 years old.

Causes

The development of hepatoblastoma involves genetic mutations in hepatoblasts that lead to uncontrolled cell growth. Contributing factors may include genetic predispositions and certain developmental abnormalities. These mutations disrupt normal cellular regulation, allowing cancerous cells to proliferate.

Risk Factors

• Premature birth (especially very low birth weight)
• Beckwith-Wiedemann syndrome
• Familial adenomatous polyposis (FAP)
• Type 1 glycogen storage disease
• Low birth weight
• Male gender (slight predominance)
• Exposure to certain environmental factors (e.g., parental smoking during pregnancy)

Symptoms

• Abdominal swelling or mass
• Unexplained weight loss
• Loss of appetite
• Nausea or vomiting
• Jaundice (yellowing of skin/eyes)
• Abdominal pain
• Fever
• Fatigue
• Pale stools or dark urine

Diagnosis

Diagnosis begins with a physical examination and assessment of symptoms. Imaging tests (e.g., ultrasound, CT, MRI) are used to detect abnormalities in the liver. A biopsy of liver tissue may be performed to confirm malignancy, and blood tests (e.g., alpha-fetoprotein levels) are often evaluated to support the diagnosis.

Treatment Options

Treatment typically involves a combination of surgery to remove the tumor, chemotherapy to shrink the tumor before surgery or eliminate remaining cancer cells, and sometimes liver transplantation for advanced or unresectable cases. Radiation therapy may be considered in specific situations.

Prognosis and Follow-Up

Prognosis depends on factors such as tumor size, stage at diagnosis, and response to treatment. Early detection and complete tumor removal generally improve outcomes. Regular follow-up care, including imaging and blood tests, is essential to monitor for recurrence or complications.

Complications

• Tumor spread to other organs (metastasis)
• Liver failure
• Bleeding or rupture of the tumor
• Side effects from chemotherapy or surgery
• Long-term organ damage from treatment

Lifestyle & Prevention

There are no specific lifestyle measures to prevent hepatoblastoma, as it is primarily linked to genetic and developmental factors. Prenatal care and monitoring for high-risk conditions may aid in early detection.

When to Seek Professional Help

Seek medical attention if a child exhibits persistent abdominal swelling, unexplained weight loss, jaundice, or other symptoms of liver dysfunction. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Document the diagnosis of hepatoblastoma with code C22.2. Ensure clinical documentation specifies the condition and any relevant details (e.g., tumor stage, treatment provided) to support accurate coding. Note that this code is specific to hepatoblastoma and should not be confused with other liver malignancies.